© 1996 American Heart Association, Inc.
Articles |
Monocyte-Induced Downregulation of Nitric Oxide Synthase in Cultured Aortic Endothelial Cells
the Vascular Biology Center and the Department of Pharmacology and Toxicology (N.M., A.P., J.D.C.), the Department of Pathology (A.A.), and the Department of Pediatrics (D.H.M.), Medical College of Georgia, Augusta; and the Armed Forces Institute of Pathology, Washington, DC (R.V., F.D.K.).
Correspondence to John D. Catravas, PhD, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2350.
Since endothelium-dependent vasodilation is altered in atherosclerosis and enhanced monocyte/endothelial interactions are implicated in early atherosclerosis, we evaluated the effects of monocytes on the endothelial nitric oxide (NO) pathway by estimating release of biologically active NO from cultured endothelial cells and levels of constitutive NO synthase (ecNOS). NO release was estimated in a short-term bioassay using endothelial cell–induced cGMP accumulation in vascular smooth muscle (SM) cells. Exposure of SM cells to porcine aortic endothelial cells (PAECs) and human aortic endothelial cells (HAECs) produced large increases in SM cGMP content; this increase was prevented by NG-nitro-L-arginine methyl ester, the inhibitor of endothelial NOS. Confluent monolayers of PAECs and HAECs cocultured with monocytes also stimulated SM cGMP formation; however, NO release from these cultures was attenuated in a coculture time (2 to 48 hours)- and monocyte concentration (20 to 200x103 per well)–dependent manner. This effect of monocyte adhesion appeared to be selective for NO release since other biochemical pathways, such as atriopeptin- and isoproterenol-induced cyclic nucleotide accumulation within the endothelial cells, were not altered by monocytes. The effects of adherent monocytes on NO release were mimicked by monocyte-derived cytokines tumor necrosis factor (TNF)-
and interleukin (IL)-1. Furthermore, the conditioned medium of monocytes contained significant quantities of these cytokines. Conditioned medium, as well as monocytes physically separated from the endothelial cells, attenuated NO release, suggesting that soluble factors may mediate the effects of monocytes. An IL-1ß neutralizing antibody fully prevented the NO dysfunction in response to directly adherent monocytes. Superoxide dismutase, catalase, 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron), and exogenous L-arginine failed to improve NO release, suggesting that oxidant stress–induced inactivation of NO or limited substrate availability were not primarily responsible for the inhibiting effects of monocytes. Western blot analysis revealed reduced quantities of ecNOS in monocyte/endothelium cocultures, as well as in HAECs treated with monocyte-conditioned medium or TNF-. Thus, adhesion of monocytes to endothelial cells and monocyte-derived secretory products downregulate steady state levels of ecNOS, an event associated with attenuated release of biologically active NO. This mechanism may potentially contribute to diminished endothelium-dependent and NO-mediated vasodilation in early atherosclerosis.
Key Words: endothelium-derived relaxing factor • cGMP • atherosclerosis • interleukin-1 • nitric oxide synthase
This article has been cited by other articles:
 |
|
 |
|
  H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF]
|
|
|
|
 |
|
 ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kovesi, D. Royston, M. Yacoub, and N. Marczin Basal and nitroglycerin-induced exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass Br. J. Anaesth., May 1, 2003; 90(5): 608 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.M. Fennessy, D.S. Moneley, J.H. Wang, C.J. Kelly, and D.J. Bouchier-Hayes Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers Circulation, January 28, 2003; 107(3): 410 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Hamilton, M. J. Brosnan, M. McIntyre, D. Graham, and A. F. Dominiczak Superoxide Excess in Hypertension and Aging : A Common Cause of Endothelial Dysfunction Hypertension, February 1, 2001; 37(2): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bundy, N. Marczin, A. H. Chester, and M. Yacoub Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1799 - H1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, B. Liliensiek, M. Kanitz, U. Schimanski, H. Bohrer, R. Waldherr, E. Martin, G. Kauffmann, R. Ziegler, and P. P. Nawroth Molecular cloning of genes differentially regulated by TNF-{alpha} in bovine aortic endothelial cells, fibroblasts and smooth muscle cells Cardiovasc Res, June 1, 1998; 38(3): 802 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Ikeda, Y. Maeda, H. Funayama, Y. Hojo, M. Ikeda, S. Minota, S. Kano, and K. Shimada Monocyte-vascular smooth muscle cell interaction enhances nitric oxide production Cardiovasc Res, March 1, 1998; 37(3): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Ito, M. Arras, B. Winkler, D. Scholz, J. Schaper, and W. Schaper Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion Circ. Res., June 19, 1997; 80(6): 829 - 837. [Abstract] [Full Text]
|
|